The activity of bacteriocins from Carnobacterium maltaromaticum UAL307 against Gram-negative bacteria in combination with EDTA treatment

FEMS Microbiology Letters

Volumn 317, Issue 2, 2011, Pages 152-159

  Martin Visscher, Leah A ^a   Yoganathan, Sabesan ^a   Sit, Clarissa S ^a   Lohans, Christopher T ^a   Vederas, John C ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Carnobacteriocin BM1; Carnocyclin A; Lantibiotics; Outer membrane; Piscicolin 126; Subtilosin A

Indexed keywords

BACTERIOCIN; CARNOBACTERIOCIN BM1; CARNOCYCLIN A; CYCLOPEPTIDE; EDETIC ACID; GALLIDERMIN; NISIN; PISCICOLIN 126; SUBTILOSIN A; UNCLASSIFIED DRUG;

BACTERIAL OUTER MEMBRANE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CARNOBACTERIUM MALTAROMATICUM; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ESCHERICHIA COLI; FOOD MICROBIOTECHNOLOGY; FOOD PRESERVATION; GROWTH INHIBITION; LETTER; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SALMONELLA TYPHIMURIUM;

BACTERIOCINS; CARNOBACTERIUM; EDETIC ACID; ESCHERICHIA COLI; NISIN; PEPTIDES; PEPTIDES, CYCLIC; PSEUDOMONAS AERUGINOSA; SALMONELLA TYPHIMURIUM;

CARNOBACTERIUM MALTAROMATICUM; ESCHERICHIA COLI; NEGIBACTERIA; POSIBACTERIA; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; SALMONELLA TYPHIMURIUM;

EID: 79952834160     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2011.02223.x     Document Type: Letter

References (47)

1. Abriouel H, Valdivia E, Gálvez A & Maqueda M (1998) Response of Salmonella choleraesuis LT2 spheroplasts and permeabilized cells to the bacteriocin AS-48. Appl Environ Microb 64: 4623-4626.
2. Ananou S, Gálvez A, Martínez-Bueno M, Maqueda M & Valdivia E (2005) Synergistic effect of enterocin AS-48 in combination with outer membrane permeabilizing treatments against Escherichia coli O157:H7. J Appl Microbiol 99: 1364-1372.
3. Bierbaum G & Sahl HG (2009) Lantibiotics: mode of action, biosynthesis and bioengineering. Curr Pharm Biotechno 10: 2-18.
4. Bover-Cid S, Jofré A, Aymerich T & Garriga M (2008) Modeling the combined effects of enterocins A and B, lactate, and EDTA on the growth of Salmonella at different temperatures. Int Microbiol 11: 11-16.
5. Boziaris IS & Adams MR (2000) Transient sensitivity to nisin in cold-shocked Gram negatives. Lett Appl Microbiol 31: 233-237.
6. Boziaris IS & Adams MR (2001) Temperature shock, injury and transient sensitivity to nisin in Gram negatives. J Appl Microbiol 91: 715-724.
7. Branen JK & Davidson PM (2004) Enhancement of nisin, lysozyme, and monolaurin antimicrobial activities by ethylenediaminetetraacetic acid and lactoferrin. Int J Food Microbiol 90: 63-74.
8. Brogden KA (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3: 238-250.
9. Chen H & Hoover DG (2003) Bacteriocins and their food applications. Compr Rev Food Sci F 2: 82-100.
10. Cotter PD, Hill C & Ross RP (2005a) Bacterial lantibiotics: strategies to improve therapeutic potential. Curr Protein Pept Sc 6: 61-75.
11. Cotter PD, Hill C & Ross RP (2005b) Bacteriocins: developing innate immunity for food. Nat Rev Microbiol 3: 777-788.
12. Cutter CN & Siragusa GR (1995a) Population reductions of Gram-negative pathogens following treatments with nisin and chelators under various conditions. J Food Protect 58: 977-983.
13. Cutter CN & Siragusa GR (1995b) Treatments with nisin and chelators to reduce Salmonella and Escherichia coli on beef. J Food Protect 58: 1028-1030.
14. Deegan LH, Cotter PD, Hill C & Ross P (2006) Bacteriocins: biological tools for bio-preservation and shelf-life extension. Int Dairy J 16: 1058-1071.
15. Delves-Broughton J (1993) The use of EDTA to enhance the efficacy of nisin towards Gram-negative bacteria. Int Biodeter Biodegr 32: 87-97.
16. Diep DB, Skaugen M, Salehian Z, Holo H & Nes IF (2007) Common mechanisms of target cell recognition and immunity for class II bacteriocins. P Natl Acad Sci USA 104: 2384-2389.
17. Elliason DJ & Tatini SR (1999) Enhanced inactivation of Salmonella typhimurium and verotoxigenic Escherichia coli by nisin at 6.5°C. Food Microbiol 16: 257-267.
18. Gálvez A, Maqueda M, Martínez-Bueno M & Valdivia E (1991) Permeation of bacterial cells, permeation of cytoplasmic and artificial membrane vesicles, and channel formation on lipid bilayers by peptide antibiotic AS-48. J Bacteriol 173: 886-892.
19. Gálvez A, Abriouel H, López RL & Ben Omar N (2007) Bacteriocin-based strategies for food biopreservation. Int J Food Microbiol 120: 51-70.
20. Gänzle MG, Weber S & Hammes WP (1999) Effect of ecological factors on the inhibitory spectrum and activity of bacteriocins. Int J Food Microbiol 46: 207-217.
21. Gao Y, van Belkum MJ & Stiles ME (1999) The outer membrane of gram-negative bacteria inhibits antibacterial activity of brochocin-C. Appl Environ Microb 65: 4329-4333.
22. Gillor O, Etzion A & Riley MA (2008) The dual role of bacteriocins as anti- and probiotics. Appl Microbiol Biot 81: 591-606.
23. Gong XD, Martin-Visscher LA, Nahirney D, Vederas JC & Duszyk M (2009) The circular bacteriocin, carnocyclin A, forms anion-selective channels in lipid bilayers. Biochim Biophys Acta 1788: 1797-1803.
24. Gursky LJ, Martin NI, Derksen DJ, van Belkum MJ, Kaur K, Vederas JC, Stiles ME & McMullen LM (2006) Production of piscicolin 126 by Carnobacterium maltaromaticum UAL26 is controlled by temperature and induction peptide concentration. Arch Microbiol 186: 317-325.
25. Helander IM, vonWright A & Mattila-Sandholm TM (1997) Potential of lactic acid bacteria and novel antimicrobials against gram-negative bacteria. Trends Food Sci Tech 8: 146-150.
26. Jack RW, Wan J, Gordon J, Harmark K, Davidson BE, Hillier AJ, Wettenhall REH, Hickey MW & Coventry MJ (1996) Characterization of the chemical and antimicrobial properties of piscicolin 126, a bacteriocin produced by Carnobacterium piscicola JG126. Appl Environ Microb 62: 2897-2903.
27. Kalchayanand N, Hanlin MB & Ray B (1992) Sublethal injury makes Gram-negative and resistant Gram-positive bacteria sensitive to the bacteriocins, pediocin AcH and nisin. Lett Appl Microbiol 15: 239-243.
28. Kawulka KE, Sprules T, Diaper CM, Whittal RM, McKay RT, Mercier P, Zuber P & Vederas JC (2004) Structure of subtilosin A, a cyclic antimicrobial peptide from Bacillus subtilis with unusual sulfur to α-carbon cross-links: formation and reduction of α-thio-α-amino acid derivatives. Biochemistry 43: 3385-3395.
29. Kjos M, Nes IF & Diep DB (2009) Class II one-peptide bacteriocins target a phylogenetically defined subgroup of mannose phosphotransferase systems on sensitive cells. Microbiology 155: 2949-2961.
30. Kordel M & Sahl HG (1985) Susceptibility of bacterial, eukaryotic and artificial membranes to the disruptive action of the cationic peptides Pep 5 and nisin. FEMS Microbiol Lett 34: 139-144.
31. Lappe R, Motta A, Sant'anna V & Brandelli A (2009) Inhibition of Salmonella Enteritidis by cerein 8A, EDTA and sodium lactate. Int J Food Microbiol 135: 312-316.
32. Martin-Visscher LA, Sprules T, Gursky LJ & Vederas JC (2008a) Nuclear magnetic resonance solution structure of PisI, a group B immunity protein that provides protection against the type IIa bacteriocin piscicolin 126, PisA. Biochemistry 47: 6427-6436.
33. Martin-Visscher LA, van Belkum MJ, Garneau-Tsodikova S, Whittal RM, Zheng J, McMullen LM & Vederas JC (2008b) Isolation and characterization of carnocyclin A, a novel circular bacteriocin produced by Carnobacterium maltaromaticum UAL307. Appl Environ Microb 74: 4756-4763.
34. Martin-Visscher LA, Gong XD, Duszyk M & Vederas JC (2009) The three-dimensional structure of carnocyclin A reveals that many circular bacteriocins share a common structural motif. J Biol Chem 284: 28674-28681.
35. Murdock CA, Cleveland J, Matthews KR & Chikindas ML (2007) The synergistic effect of nisin and lactoferrin on the inhibition of Listeria monocytogenes and Escherichia coli O157:H7. Lett Appl Microbiol 44: 255-261.
36. Parisien A, Allain B, Zhang J, Mandeville R & Lan CQ (2008) Novel alternatives to antibiotics: bacteriophages, bacterial cell wall hydrolases, and antimicrobial peptides. J Appl Microbiol 104: 1-13.
37. Quadri LEN, Sailer M, Roy KL, Vederas JC & Stiles ME (1994) Chemical and genetic characterization of bacteriocins produced by Carnobacterium piscicola LV17B. J Biol Chem 269: 12204-12211.
38. Raetz CRH & Whitfield C (2002) Lipopolysaccharide endotoxins. Annu Rev Biochem 71: 635-700.
39. Rossi LM, Rangasamy P, Zhan J, Qiu XQ & Wu GY (2008) Research advances in the development of peptide antibiotics. J Pharm Sci 97: 1060-1070.
40. Shelburne CE, An FY, Dholpe V, Ramamoorthy A, Lopatin DE & Lantz MS (2007) The spectrum of antimicrobial activity of the bacteriocin subtilosin A. J Antimicrob Chemoth 59: 297-300.
41. Silkin L, Hamza S, Kaufman S, Cobb SL & Vederas JC (2008) Spermicidal bacteriocins: lacticin 3147 and subtilosin A. Bioorg Med Chem Lett 18: 3103-3106.
42. Stevens KA, Sheldon BW, Klapes NA & Klaenhammer TR (1991) Nisin treatment for inactivation of Salmonella species and other Gram-negative bacteria. Appl Environ Microb 57: 3613-3615.
43. Thennarasu S, Lee DK, Poon A, Kawulka KE, Vederas JC & Ramamoorthy A (2005) Membrane permeabilization, orientation, and antimicrobial mechanism of subtilosin A. Chem Phys Lipids 137: 38-51.
44. Ukuku DO & Fett WF (2002) Effectiveness of chlorine and nisin-EDTA treatments of whole melons and fresh-cut pieces for reducing native microflora and extending shelf-life. J Food Safety 22: 231-253.
45. Vaara M (1992) Agents that increase the permeability of the outer-membrane. Microbiol Rev 56: 395-411.
46. Yan LZ, Gibbs AC, Stiles ME, Wishart DS & Vederas JC (2000) Analogues of bacteriocins: antimicrobial specificity and interactions of leucocin A with its enantiomer, carnobacteriocin B2, and truncated derivatives. J Med Chem 43: 4579-4581.
47. Zhang SS & Mustapha A (1999) Reduction of Listeria monocytogenes and Escherichia coli O157:H7 numbers on vacuum-packaged fresh beef treated with nisin or nisin combined with EDTA. J Food Protect 62: 1123-1127.